Cladribine is rapidly absorbed with maximum concentration reached 30–50 min after oral administration and 0–20% bound to plasma protein. The half-life varies from 5.6 to 7.6 h and 18.4 to 19.7 ...

The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS).

The pharma group has been battling an attempt by Chinese drugmaker HEC Pharma to bring a generic version to market ... Merck KGaA's Mavenclad (cladribine), Bristol-Myers Squibb's Zeposia (ozanimod ...

Novartis has blocked an attempt by Chinese drugmaker HEC Pharma to launch a generic version of its big ... (ocrelizumab), Merck KGaA's Mavenclad (cladribine), Bristol-Myers Squibb's Zeposia ...